Biotech Financing Options and Their Implications episode artwork

EPISODE · Oct 6, 2022 · 39 MIN

Biotech Financing Options and Their Implications

from PharmaTalkRadio · host Conference Forum

In this session recorded at CMO Summit 2022, the panel discusses: What CMOs need to know about series funding, crossover and IPOHow to think about when to engage in these financing options based on the company stage, milestones, and budgetHow CMOs can best support the decision-making and fundraising processes Speakers: Nerissa Kreher, MD, MBA, CMO, Entrada TherapeuticsGeoff Meyerson, MBA, Co-Founder & CEO, Locust WalkTariq Kassum, MD, CEO, Celsius TherapeuticsAnn Barbier, MD, PhD, CMO, CAMP4 Therapeutics

Episode metadata supplied by the publisher feed · Published Oct 6, 2022

Embed this episode

Ready to play

Biotech Financing Options and Their Implications

0:00 39:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PharmaTalkRadio?

This episode is 39 minutes long.

When was this PharmaTalkRadio episode published?

This episode was published on October 6, 2022.

Can I download this PharmaTalkRadio episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!